Publication:
Role of IGF2 in the Study of Development and Evolution of Prostate Cancer.

Simple item page
dc.contributor.authorPorras-Quesada, P
dc.contributor.authorGonzalez-Cabezuelo, J M
dc.contributor.authorSanchez-Conde, V
dc.contributor.authorPuche-Sanz, I
dc.contributor.authorArenas-Rodriguez, V
dc.contributor.authorGarcia-Lopez, C
dc.contributor.authorFlores-Martin, J F
dc.contributor.authorMolina-Hernandez, J M
dc.contributor.authorAlvarez-Cubero, M J
dc.contributor.authorMartinez-Gonzalez, L J
dc.contributor.authorVazquez-Alonso, F
dc.date.accessioned2023-05-03T13:40:12Z
dc.date.available2023-05-03T13:40:12Z
dc.date.issued2021-11-29
dc.description.abstractProstate Cancer (PC) is commonly known as one of the most frequent tumors among males. A significant problem of this tumor is that in early stages most of the cases course as indolent forms, so an active surveillance will anticipate the appearance of aggressive stages. One of the main strategies in medical and biomedical research is to find non-invasive biomarkers for improving monitoring and performing a more precise follow-up of diseases like PC. Here we report the relevant role of IGF2 and miR-93-5p as non-invasive biomarker for PC. This event could improve current medical strategies in PC.
dc.description.versionSi
dc.identifier.citationPorras-Quesada P, González-Cabezuelo JM, Sánchez-Conde V, Puche-Sanz I, Arenas-Rodríguez V, García-López C, et al. Role of IGF2 in the Study of Development and Evolution of Prostate Cancer. Front Genet. 2022 Jan 4;12:740641.
dc.identifier.doi10.3389/fgene.2021.740641
dc.identifier.issn1664-8021
dc.identifier.pmcPMC8790605
dc.identifier.pmid35095996
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790605/pdf
dc.identifier.unpaywallURLhttps://www.frontiersin.org/articles/10.3389/fgene.2021.740641/pdf
dc.identifier.urihttp://hdl.handle.net/10668/20572
dc.journal.titleFrontiers in genetics
dc.journal.titleabbreviationFront Genet
dc.language.isoen
dc.organizationHospital Torrecárdenas
dc.organizationHospital Universitario Virgen de las Nieves
dc.organizationCentro Pfizer-Universidad de Granada-Junta de Andalucía de Genómica e Investigación Oncológica-GENYO
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.organizationHospital Universitario de Jaén
dc.page.number12
dc.publisherFrontiers Research Foundation
dc.pubmedtypeJournal Article
dc.relation.publisherversionhttps://doi.org/10.3389/fgene.2021.740641
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectIGF2
dc.subjectbiomarker
dc.subjectexpression patterns
dc.subjectmiR-93-5p
dc.subjectmiRNA
dc.subjectprecision medicine
dc.subjectprostate cancer
dc.subject.decsBiomarcadores
dc.subject.decsEspera vigilante
dc.subject.decsEstudios de seguimiento
dc.subject.decsMasculino
dc.subject.decsMicroARNs
dc.subject.decsNeoplasias de la próstata
dc.subject.meshMale
dc.subject.meshFollow-Up Studies
dc.subject.meshWatchful Waiting
dc.subject.meshProstatic Neoplasms
dc.subject.meshBiomarkers
dc.subject.meshMicroRNAs
dc.subject.meshBiomedical Researchmes
dc.titleRole of IGF2 in the Study of Development and Evolution of Prostate Cancer.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number12
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Thumbnail Image
Name:
PMC8790605.pdf
Size:
2.07 MB
Format:
Adobe Portable Document Format
Download
No Thumbnail Available
Name:
Porras_RoleOf_MaterialSuplementario.zip
Size:
46.31 KB
Format:
Download

Collections

Centro Pfizer-Andalucía de Genómica e Investigación Oncológica (GENYO)
Instituto de Investigación Biosanitaria de Granada (ibsGRANADA)
SAS - Hospital Universitario de Jaén
SAS - Hospital Universitario Torrecárdenas
SAS - Hospital Universitario Virgen de las Nieves

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía